NexGel Inc NXGL
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
News
-
NEXGEL Regains Compliance with Nasdaq Listing Requirement
-
NEXGEL Announces 1-for-20 Reverse Stock Split Effectiveness
-
NEXGEL Announces Dial-In Details for Investor Update Call
-
NEXGEL Announces Date for Investor Update Call
-
NEXGEL ANNOUNCES LEADERSHIP TRANSITION AND STRATEGIC REVIEW INITIATIVE
-
NEXGEL Reports Second Quarter 2026 Financial Results
Trading Information
- Previous Close Price
- $3.88
- Day Range
- $3.50–3.90
- 52-Week Range
- $3.00–53.60
- Bid/Ask
- $3.45 / $4.15
- Shares Outstanding
- 487,383.00
- Market Cap
- $1.71M
- Volume/Avg
- 60,142 / 108,976
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.12
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
NexGel Inc manufactures high water content, electron beam cross-linked, aqueous polymer hydrogels, or gels, used for wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company specializes in custom gels by capitalizing on proprietary manufacturing technologies. The gels and consumer products are manufactured using proprietary and non-proprietary mixing, coating and cross-linking technologies.
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- Stock Style Box
- Small Value
- Total Number of Employees
- 19
- Website
- https://www.nexgel.com
Valuation
|
Metric
|
NXGL
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | 0.34 |
Price/Sales | 0.12 |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
|
Metric
|
NXGL
|
|---|---|
Quick Ratio | 0.11 |
Current Ratio | 0.43 |
Interest Coverage | −1.68 |
Quick Ratio
NXGL
Profitability
|
Metric
|
NXGL
|
|---|---|
Return on Assets (Normalized) | −50.42% |
Return on Equity (Normalized) | −151.38% |
Return on Invested Capital (Normalized) | −51.80% |
Return on Assets
NXGL
Medical Instruments & Supplies Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Intuitive Surgical Inc
ISRG
| LOCK|$!CpY&# | LOCK|?# | $153B | |||
| Becton Dickinson & Co
BDX
| LOCK|!@Q | LOCK|^H?F | $54B | |||
| Alcon Inc
ALC
| LOCK|X!#^$# | LOCK|D##B? | $35B | |||
| ResMed Inc
RMD
| LOCK|B^!ZS<< | LOCK|q?mW | $32B | |||
| West Pharmaceutical Services Inc
WST
| LOCK|G<w!%&wk | LOCK|BW | $29B | |||
| Medline Inc Ordinary Shares - Class A
MDLN
| LOCK|w<DSJK> | LOCK|t$jP | $28B | |||
| Solventum Corp
SOLV
| LOCK|YY&gl%H | LOCK|?^ | $14B | |||
| Baxter International Inc
BAX
| LOCK|k>r | LOCK|hMLQ | $12B | |||
| The Cooper Companies Inc
COO
| LOCK|^$>#<D | LOCK|@^>w | $11B | |||
| Repligen Corp
RGEN
| LOCK|K&X#fY#Q | LOCK|>hd<$ | $11B |
United States